Printer Friendly

Relationship between selected hormonal and metabolic parameters at birth and blood pressure during pre-adolescence/Relacion entre parametros endocrino-metabolicos al nacimiento y la presion arterial durante la pre-adolescencia.

The possibility of an intrauterine programming of blood pressure later on in life and the risk of various chronic diseases attracts considerable interest. This hypothesis is supported by a growing number of observational and experimental studies (1) although concerns have been raised on some methodological limitations of these studies, the different outcomes selected and the inconsistencies of the results (2). Furthermore, most studies used birth weight and other anthropometric measures at birth as proxy indicators for intrauterine growth impairment without providing physiological or metabolic explanatory data for the possible mechanisms underlining these associations. It was observed (3) endocrinological alterations associated with intrauterine growth restriction, particularly higher growth hormone values in cord blood at birth, perhaps as a functional compensatory mechanism of the hypothalamic-pituitary axis to foetal growth restriction (3). As a follow-up to these results, we have conducted the present prospective study specifically designed to evaluate the following <<a-priori>> question: is there a relationship between selected hormonal and metabolic parameters at birth and at 8 years of age with blood pressure during pre-adolescence? Also, we have evaluated the differences in postnatal growth and blood pressure between intrauterine growth restriction (IUGR) and normal birth weight (NBW) children.

MATERIAL AND METHODS

Original cohort. This is a follow-up pilot study of a cohort of infants born between 1995 and 2004 at the Department of Obstetrics and Gynaecology, Principe de Asturias University Hospital, Alcala de Henares, Madrid, Spain. The original population included 94 singleton pregnancies, without congenital malformations and/or chromosomal abnormalities that delivered at term (>37 weeks to <42 weeks of gestation). This study was specifically conducted to explore the association between newborn anthropometric and endocrine parameters, the present follow-up represents a natural extension of this initial research (3). Gestational age was calculated using the date of the last menstrual period and first trimester ultrasound measures and corroborated by physical examination of the newborn. In case of disagreement of more than two weeks among the different methods, early ultrasound dating was used. There were 47 fetus suspected at ultrasound examination to have intrauterine growth restriction (IUGR), of whom 31 actually had birth weight at or below the tenth percentile of a local standard confirming the diagnosis (3) they constitute the IUGR population. Forty-seven newborns were identified immediately after birth of each suspected IUGR and selected as controls, if they had birth weight >10th percentile of the same local standard (3); they are the normal birth weight population. There were two eligible control newborns that could not be included because cord blood collection was not possible. Therefore the initial study population includes 31 confirmed IUGR and 45 NBW infants (3).

Follow-up. Between 1 November 2003 and 30 September 2004 (on average 8 years postpartum) all the 76 families of the newborns originally studied were identified from hospital records and contacts were attempted to their last known address; those that could not be located were contacted using the social security number registered in the medical record and the new address reported to the regional health care authority. One IUGR child died at one year of age of meningitis and 3 IUGR and 8 NBW refused to participate. Thus, we were able to locate 64 children from the original cohort (84%) and assessed during childhood 27 IUGRs (87%) and 37 NBW infants (82%).

Blood extractions, physical examinations and a brief pediatric history were conducted at the hospital between 8 and 9 am. Height was measured using custom-made stadiometers with the children wearing no shoes. Weight was measured using calibrated scale with children in light clothing. Skinfold measurement was obtained at the triceps and subscapular sites with <<Holtain caliper, UK>>. All anthropometric measurements were taken twice. Body Mass Index (BMI) was calculated as weight in kilograms divided by the square of height in meters. Examinations of the children were conducted at a mean age of 8.0 (SD 1.1) years in the IUGR group and 8.4 (SD 1.0) years in the normal birth weight group.

Systolic and diastolic blood pressure were measured in the child's right arm, after a period of rest, in a seated position with the arm resting on a supportive surface at the heart level, by only one examiner, a nurse-midwife specifically trained for this study. She was blinded to the birth characteristics of the children and to the specific hypotheses of the study. Two consecutive measures of systolic and diastolic blood pressure (Korotkoff V sound; disappearance of sounds) were taken five minutes apart using a standard mercury sphygmomanometer with a cuff bladder size of 15 cm by 9 cm following the recommended criteria (4). The average of the two blood pressure recordings was considered as the blood pressure for the analyses.

IUGR and NBW children were compared at a mean age of 8 years using standard statistical methods for mean and proportions. Multiple linear regression analyses were conducted using as dependent variable blood pressure during childhood and, as independent variables, the hormonal and metabolic values measured in cord blood and blood samples at assessment. Adjustments were made by gender, fetal growth category (IUGR versus NBW), gestational age at birth, maternal smoking and educational level, as well as children's age and body mass index (BMI) at assessment, as possible confounding variables. We used the Statview II statistical package in all analyses.

This study was approved following the routine review process of the Department of Obstetrics and Gynaecology of the Principe de Asturias University Hospital, Alcala de Henares, Madrid, Spain and the Institutional Ethical Committee. Mothers provided informed consent for the blood pressure measurements and blood extractions of their children.

Laboratory methods. Arterial blood umbilical cord samples were taken immediately after birth, at umbilical cord clamping but before cutting the cord. Each sample of 20 ml was processed in duplicate, centrifuged and stored at -40[degrees]C until assay. At age 8 years, fasting blood samples were collected by venoclisis of the cubital vein. 15 ml of blood were extracted and processed in the same as the umbilical cord blood samples, the same serum parameters as at birth were determined. The laboratory team was blind to clinical condition of the patient.

We measured in these samples selected hormonal and metabolic parameters as growth hormone (GH), insulin growth factor-I (IGF-I), cortisol, insulin, tirostimuline hormone (TSH), prolactin, glucose, cholesterol, triglycerides, albumin and magnesium. We did not measure IGF-I binding protein independently. IGF-I was measured by radio immunoassay (Lab. Systems, USA), insulin and GH by colorimetric enzymoimmunoassay (Medgenix Diagnostics, Belgium) (5). For insulin intra-assay coefficient of variation of 3.6%, inter-assay coefficient of variation of 7.1% for GH; TSH by fluorometric assay (Baxter S.A., USA) (6); cortisol by fluorescence polarization immunofluorometric assay (Abbott SA, USA), intra-assay coefficient of variation of 4.1%, inter-assay coefficient of variation of 7.2%; prolactin by a immunofluorometric assay (Pharmacia LKB-Wallac, Finland), intra-assay coefficient of variation of 3.3%, inter-assay coefficient of variation of 4%. The metabolic parameters (insulin and cholesterol levels) were measured with the Hitachi 717 autoanalyzer, Tokyo, Japan. A significant statistical difference was considered with a p value lower than 0.05.

RESULTS

The maternal age was similar between the groups (Table 1). The weeks of gestational age at birth and the height of the newborns were similar between the groups (Table 1). The mean of the birthweight and the neonatal ponderal index was different between the groups (Table 1). Tables 2 and 3 show data for hormonal and metabolic parameters at birth and at 8 years of age for the children included classified as intrauterine growth restriction (IUGR) and normal birth weight (NBW). At birth IUGR children had higher cord blood growth hormone levels but lower insulin, thyroid stimulating hormone and cholesterol values (Table 2). IGF-I intra-assay coefficient of variation of 4.2%, inter-assay coefficient of variation of 5.1%. We found no statistical significant differences between groups of these parameters at age of 8 years although growth hormone levels remained higher in the IUGR group (Table 3).

At 8 years of age IUGR children were shorter, tended to be lighter but had similar BMI than the NBW group (Table 4). At this age, the mean systolic and diastolic blood pressure in the IUGR group was lower as compared with the NBW group without statistical difference. IUGR children have mean systolic and diastolic blood pressure 3.64 mmHg and 2.63 mmHg respectively lower than NBW children (PNS) after adjusting by Body Mass Index, gender and age at assessment.

At 8 years of age, in the crude analysis, for the complete population, there was an overall positive relationship between BMI (kg/[m.sup.2]) and systolic (beta=1.15; 95% confidence interval 0.33 to 1.96 (mmHg) (p=0.006)) and diastolic blood pressure (beta=1.16; 95% confidence interval 0.55 to 1.77 (mmHg) (p=0.003).

Table 5 presents the multiple linear regression analysis between hormonal and metabolic parameters in cord blood at birth and at 8 years of age as independent variables, and blood pressure at 8 years of age as the dependent variable. Results presented are adjusted by gender, gestational age at birth, age and body mass index of the child at the time of blood pressure measurement as well as for the other variables in the regression model, including intrauterine growth category (IUGR vs. NBW).

Independent of the other variables considered, growth hormone at birth and at age 8 years were negatively associated with systolic blood pressure at age 8 years. There is the same tendency with diastolic blood pressure. Adding to this regression model TSH, insulin, prolactin, cholesterol, glucose, albumin and magnesium did not change the observed results (Table 5). The mothers' educational level, used as a proxy indicator for socioeconomic status, did not modify these relationships either.

DISCUSSION

We have prospectively studied a cohort, from pregnancy to childhood, with a priori defined objectives, using biochemical indicators of fetal growth and nutritional status specifically collected for this study. As was expected the perinatal characteristics of the newborns were according with the clinical status of the groups (Table 1) and the body mass index was correlated with both systolic and diastolic blood pressure (p=0.003). The diagnosis of IUGR was made by both ultrasound examinations during pregnancy and birthweight. The small sample size of the original population, as well as that of the follow-up cohort, is a limitation but the response rate of 84% is very adequate within the expected rate for follow-up studies in children and adolescents (7). Although we followed presently recommended techniques for systolic and diastolic blood pressure measurement in children (4), the single measurement of blood pressure is also a limitation because longitudinal blood pressure recordings better represent the true blood pressure level of a child. Unfortunately, placental weight was not available, limiting the possibility of exploring the fetal-placental ratio/blood pressure relationship.

This study presents evidence that serum growth hormone (GH) at birth and at 8 years were negatively associated with systolic blood pressure during childhood independently of the gestational age, gender, age, IUGR/ NBW status, and BMI at the time of blood pressure assessment. This evidence supports the suggestion (8) that the fetal activation of the hypothalamic-pituitary axis and its long-term effect is related to the programming of cardiovascular development and blood pressure during childhood.

Disturbances in the GH/insulin-like growth factor I axis are recognized as related to post natal growth failure among IUGR infants (9) and their influence during growth hormone treatment among IUGR infants (10). However, these disturbances are not always consistent in the literature, perhaps due to the molecular heterogeneity of GH and levels of bioinactive but immunologically active GH molecules.

There are several reports documenting lower mean estimated secretion rates of GH in prepubertal short children born IUGR (11), while others failed to demonstrate differences in urinary GH by patterns of catch-up growth among IUGR infants (12). Furthermore, the relationship between GH and IGF-I is also influenced by race and gender (13). An increased proportion of circulating non-22-kilodalton GH is reported in short children (14) while children 2 to 5 years born IUGR were found to have high basal GH levels (11). Finally, a non statistical significant negative relationship was observed between urinary GH and blood pressure at 9 years of age (15). It is important to point out that all this evidence is related to hormonal values during childhood, while our paper presents data on hormonal values at birth and at the time of blood pressure measure before puberty.

The mechanisms responsible for the negative association between growth hormone at birth and blood pressure during childhood are unclear at this point. The growth hormone increase among IUGR infants can be seen as a response to foetal growth alterations most likely unrelated to IGF-I. In this regard, the observed negative association between growth hormone and blood pressure at age 8 could be seen as a chronic adaptation to a growth deficit becoming a risk factor for adult diseases particularly among short children. Interestingly, the higher GH levels at birth among IUGR children are not sufficient for a growth catch-up during childhood. Furthermore, our results provide empirical support for the suggestion that blood pressure and somatic growth in children are governed by the similar process (16) which, as we have shown, is initiated during fetal life, and is still present during childhood (1).

This process would involve hormones with known growth activity in uterus, such as IGF-I (17) or ACTH with effect on blood pressure increase (18). It is possible that intrauterine hormonal, nutritional or organ growth alterations can stimulate in uterus, the growth hormone -IGF-I axis predisposing some newborns to higher blood pressure when confronted with rapid growth during childhood. This could be the case of a subgroup of IUGR infants with higher levels of growth hormone at birth (3) or those with high response to growth hormone-releasing hormone (19). It is clear that the development of the cardiovascular system (antenatal and postnatal) as well as the regulation of blood pressure up to adulthood is controlled by several interrelated mechanisms (20). The evidence presented here represents one of such mechanisms complementing others, nutritional or environmental, which are yet to be disentangled. We conclude that the alterations on blood pressure can begin in fetal life were levels of GH could have an important role.

Recibido para publicacion enero 18, 2008 Aceptado para publicacion enero 15, 2009

REFERENCES

(1.) Cheung YB, Low L, Osmond C, Barker D, Karlberg J. Fetal growth and early postnatal growth are related to blood pressure in adults. Hypertension. 2000; 36: 795-800.

(2.) Vehaskari VM, Aviles DH, Manning J. Prenatal programming of adult hypertension in the rat. Kidney Int. 2001; 59: 238-45.

(3.) Nieto-Diaz A, Villar J, Matorras-Weinig R, Valenzuela-Ruiz P. Intrauterine growth retardation at term: association between anthropometric and endocrine parameters. Acta Obstet Gynecol Scand. 1996; 75: 127-31.

(4.) National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents: Update on the 1987 Task Force. Report on high blood pressure in children and adolescents. A Working Group from the National High Blood Pressure Education Program. Pediatrics. 1996; 98: 649-58.

(5.) Hashida S, Nakawaga K, Ishikawa E, Ohtaki S. Basal levels of human growth hormone (GH) in normal serum. Clin Chem Acta. 1985; 1: 85-6.

(6.) Wilke TJ, Eastment HT. Discriminative ability of tests for free and total thyroid hormones in diagnosing thyroid disease. Clin Chem. 1986; 32: 1746-50.

(7.) Salazar J, Daly K, Scott Giebink G, Lindgen B, Liebeler C, Melond M, et al. Low cord blood pneumococcal immunoglobulin G (lgG) antibodies predict early onset acute otitis media in infancy. Am J Epidemiol. 1997; 145: 1048-56.

(8.) Fall CH, Pandit AN, Law CM. Size at birth and plasma insulin-like growth factor-I concentrations. Arch Dis Childhood. 1995; 73: 287-93.

(9.) Sas T, Mulder P, Hokken-Koelega A. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency. J Clin Endocrinol Metab. 2000; 85: 3786-92.

(10.) Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age. J Clin Endocrinol Metab. 1996; 81: 3902-8.

(11.) Albertsson-Wikland K, Boguszewski M, Karlberg J. Children born small-for-gestational age: postnatal growth and hormonal status. Horm Res. 1998; 49 Suppl 2: 7-13.

(12.) Garcia H, Henriquez C, Ugarte F, Fernandez E. GH-IGF axis during catch up growth in small for gestational age (SGA) infants. J Pediatr Endocrinol Metab. 1996; 9: 561-7.

(13.) Xiaozhang J, Srinivasan SR, Dalferes E, Berenson G. Plasma insulin-like growth factor 1 distribution and its relatin to blood pressure in adolescents. Am J Hypertens. 1997; 10: 714-9.

(14.) Boguszewski CL, Jansson C, Boguszewski MCS, Rosberg S. Increased proportion of circulating non-22-kilodalton growth hormone isoforms in short children: a possible mechanism for growth failure. J Clin Endocrinol Metab. 1997; 82: 2944-9.

(15.) Fall CHD, Clark PM. Urinary GH and IGF-I excretion in nine year-old children: relation to sex, current size and size at birth. Clin Endocrinol. 2000; 53: 69-76.

(16.) Lever AF, Harrap SB. Essential hypertension: a disorder of growth with origins in childhood? J Hypertens. 1992; 10: 101-20.

(17.) Guevara-Aguirre J. Insulin-like growth factor I--An important intrauterine growth factor. N Engl J Med. 1996; 335: 1389-91.

(18.) Scoggins BA, Denton DA, Whitworth JA, Coghlan JD. ACTH dependent hypertension. Clin Exp Hypertens (A). 1984; 6: 599-646.

(19.) Job JC, Chatelain P, Rochiccioli P, Ponte C, Olivier M, Sagmerd L. Growth hormone response to a bolus injection of 1-44 growth-hormone-releasing hormone in very short children with intrauterine onset of growth failure. Horm Res. 1990; 33: 161-5.

(20.) Maulik D, Frances Evans J, Ragolia L. Fetal growth restriction: pathogenic mechanisms. Clin Obstet Gynecol. 2006; 49: 219-27.

ANIBAL NIETO, MD, PHD [1], JULIAN A. HERRERA, MD [2], JOSE VILLAR MD [3], ROBERTO MATORRAS, MD, PHD [4], CLARA PATRON, ENF [1], CAROLINA CARRALAFUENTE, MD [1]

[1.] Associate Professor, Department of Obstetrics and Gynaecology, Hospital Universitario Principe de Asturias, Universidad de Alcala, Alcala de Henares, Madrid, Spain. e-mail: anibal.nieto@uah.es clmanzanara@hotmail.com

[2.] Emeritus Head Professor, Department of Family Medicine, Universidad del Valle, Cali, Colombia. e-mail: herreja@univalle.edu.co

[3.] UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organization, Geneva. e-mail: villarj@who.int

[4.] Hospital de Cruces, Baracaldo, University del Pais Vasco, Vizcaya, Spain.
Table 1
Perinatal characteristics at birth of 64 children.
Hospital Universitario Principe de Asturias, Alcala de Henares, Madrid,
Spain. 1995

              Parameter                   Intrauterine growth
                                          restriction (N= 27)

Gestation age (wk.) (Mean/SD)              39.1 [+ or -] 1.4
Maternal age (years) (Mean/SD)             26.6 [+ or -] 5.8
Weight (at birth (g) (Mean/SD)             2487 [+ or -] 221
Height (at birth) (cm) (Mean/SD)          48.09 [+ or -] 2.31
Neonatal ponderal index                    2.44 [+ or -] 0.33

              Parameter                   Normal birth weight       p
                                                 (N=37)

Gestation age (wk.) (Mean/SD)              39.6 [+ or -] 1.3       0.09
Maternal age (years) (Mean/SD)             26.9 [+ or -] 5.8       0.62
Weight (at birth (g) (Mean/SD)             3269 [+ or -] 345      <0.01
Height (at birth) (cm) (Mean/SD)          48.15 [+ or -] 2.16      0.87
Neonatal ponderal index                    2.70 [+ or -] 0.23     <0.01

Table 2
Hormonal and metabolic characteristics at birth of 64 children.
Hospital Universitario Principe de Asturias, Alcala de Henares, Madrid,
Spain. 1995

          Parameter                        Intrauterine growth
                                           restriction (N= 27)

Growth hormone (ng/ml)                         25.8 (3.3) *
Insulin-like growth factor I (mU/ml)            0.6 (0.09)
Cortisol (ug/dI)                               15.9 (1.9)
Insulin (U/ml)                                  2.5 (0.6)
Thyroid stimulating hormone(uU/ml)              9.2 (0.8)
Prolactin (ng/mI)                             226.9 (12.4)
Glucose (mg/dl)                                86.0 (5.1)
Cholesterol (mg/dl)                            60.5 (2.2)
Triglycerides (mg/dl)                          35.6 (2.8)
Albumin (g/dl)                                  3.9 (0.05)
Total protein                                   5.9 (0.1)
Magnesium (mg/dl)                               1.9 (0.05)

          Parameter                        Normal birth weight     p
                                                 (N=37)

Growth hormone (ng/ml)                         15.7 (1.5)        0.0008
Insulin-like growth factor I (mU/ml)            0.7 (0.06)       0.3
Cortisol (ug/dI)                               17.6 (1.8)        0.2
Insulin (U/ml)                                  5.2 (0.9)        0.05
Thyroid stimulating hormone(uU/ml)             14.3 (1.7)        0.03
Prolactin (ng/mI)                             208.2 (12.3)       0.2
Glucose (mg/dl)                                96.0 (3.9)        0.13
Cholesterol (mg/dl)                            70.3 (2.6)        0.01
Triglycerides (mg/dl)                          37.3 (1.9)        0.29
Albumin (g/dl)                                  4.2 (0.04)       0.009
Total protein                                   6.0 (0.08)       0.5
Magnesium (mg/dl)                               1.8 (0.02)       0.01

* Mean (standard error)

Table 3
Hormonal and metabolic characteristics at age 8 years of 64 children.
Hospital Universitario Principe de Asturias, Alcala de Henares, Madrid,
Spain. 2004

                Parameter                    Intrauterine growth
                                             restriction (N= 27)

Growth hormone (ng/ml)                           1.2 (0.6) *
Insulin-like growth factor I (ng/ml)           184.1 (16.3)
Cortisol (ug/dl)                                16.5 (1.2)
Insulin (U/Mi)                                  13.2 (2.5)
Thyroid stimulating hormone (U/ml)               2.9 (0.2)
Prolactin (ng/ml)                                7.4 (0.6)
Glucose (mg/dl)                                 85.3 (1.5)
Cholesterol (mg/dl)                            169.6 (5.6)
Triglycerides (mg/dl)                           73.8 (9.2)
Total protein (g/dl)                             7.4 (0.07)
Magnesium (mg/dl)                                1.9 (0.06)

                Parameter                    Normal birth weight     p
                                                    (N=37)

Growth hormone (ng/ml)                           0.9 (0.4)          0.6
Insulin-like growth factor I (ng/ml)           196.6 (17.7)         0.6
Cortisol (ug/dl)                                14.7 (1.4)          0.3
Insulin (U/Mi)                                  11.7 (1.9)          0.6
Thyroid stimulating hormone (U/ml)               2.8 (0.2)          0.8
Prolactin (ng/ml)                               10.9 (2.2)          0.1
Glucose (mg/dl)                                 88.6 (1.5)          0.1
Cholesterol (mg/dl)                            168.3 (6.7)          0.8
Triglycerides (mg/dl)                           75.8 (9.2)          0.8
Total protein (g/dl)                             7.3 (0.08)         0.4
Magnesium (mg/dl)                                1.7 (0.09)         0.1

* Mean (standard error)

Table 4
Clinical characteristics at age 8 years of 64 children.
Hospital Universitario Principe de Asturias, Alcala de Henares, Madrid,
Spain. 2004

         Parameter                      Intrauterine growth
                                        restriction (N= 27)

Age (years)                                 8.0 (1.05) *
Weight (kg)                                28.2 (6.67)
Height (cm)                               128.9
Body mass index (kg/[m.sup.2])             17.1 (3.13)
Systolic blood pressure (mmHg)             87.2 (11.95)
Diastolic blood pressure (mmHg)            53.5 (6.12)

         Parameter                      Normal birth weight      p
                                             (N=37)

Age (years)                                 8.4 (1.04)          0.2
Weight (kg)                                31.7 (9.75)          0.1
Height (cm)                               133.9                 0.04
Body mass index (kg/[m.sup.2])             17.6 (3.28)          0.5
Systolic blood pressure (mmHg)             90.9 (10.04)         0.1
Diastolic blood pressure (mmHg)            56.1 (9.94)          0.2

* Mean (standard deviation)

Table 5
Multiple regression analysis of the association between biochemical
indicators and blood pressure. Hospital Universitario Principe de
Asturias, Alcala de Henares, Madrid, Spain

  Independent variable              Systolic blood pressure

At birth                            Regression coefficients
Growth hormone (ng/ml)             -0.143 * (-0.356 to 0.069)
IGF1 (mU/ml)                       -0.401 (-8.375 to 7.573)
Cortisol (ug/dl)                    0.145 (-0.164 to 0.455)
Insulin (uU/ml)                    -0.041 (-0.682 to 0.6)
TSH (uU/ml)                         0.055 (-0.19 to 0.301)
Prolactin (ng/ml)                   0.005 (-0.036 to 0.046)
At 8 years of age
Growth hormone (ng/ml)             -1.076 (-2.271 to 0.12)
IGF1 (ng/ml)                       -0.013 (-0.051 to 0.025)
Cortisol (ug/dl)                    0.09 (0.322 to 0.502)
Insulin (uU/ml)                     0.148 (-0.124 to 0.421)
TSH (uU/ml)                         1.863 (-1.023 to 4.479)
Prolactin (ng/ml)                  -0.186 (-0.501 to 0.13)

  Independent variable              Diastolic blood pressure

At birth                            Regression coefficients
Growth hormone (ng/ml)             -0.078 (-0.244 to 0.088)
IGF1 (mU/ml)                        2.598 (-3.642 to 8.838)
Cortisol (ug/dl)                    0.137 (-0.105 to 0.379)
Insulin (uU/ml)                    -0.133 (-0.635 to 0.369)
TSH (uU/ml)                        -0.071 (-0.264 to 0.121)
Prolactin (ng/ml)                  -0.0004 (-0.032 to 0.033)
At 8 years of age
Growth hormone (ng/ml)             -0.488 (-1.423 to 0.448)
IGF1 (ng/ml)                       -0.029 (+) (-0.059 to 0.001)
Cortisol (ug/dl)                    0.088 (-0.234 to 0.411)
Insulin (uU/ml)                     0.096 (-0.116 to 0.309)
TSH (uU/ml)                        -0.777 (-1.482 to 3.036)
Prolactin (ng/ml)                  -0.276 (+) (-0.523 to -0.029)

There were 27 intrauterine growth restricted and 37 normal birth weight
newborns/children pairs. All regression coefficients were adjusted by
gender, gestational age at birth, BMI at 8 years and IUGR/NBW category

* Regression coefficients and 95% confidence interval in mmHg.
(+) p=0.05
COPYRIGHT 2009 Facultad de Salud-Universidad de Valle
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Nieto, Anibal; Herrera, Julian A.; Villar, Jose; Matorras, Roberto; Patron, Clara; Carralafuente, Ca
Publication:Colombia Medica
Article Type:Report
Date:Jan 1, 2009
Words:4165
Previous Article:Tuberculosis: expression of beauty, horror and pain/Tuberculosis: expresion de belleza, horror y dolor.
Next Article:Evaluation of microphthalmia associated transcription factor (MITF) expression in peripheral blood of a population with malign melanoma and control...
Topics:

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |